RepRegen™ Ltd. (Formerly Known as BioCeramic Therapeutics) Receives Visit from His Royal Highness, Prince Andrew, Duke of York
3/2/2011 10:34:07 AM
More...
|
RepRegen™ Ltd. (Formerly Known as BioCeramic Therapeutics) Seeks US FDA 510(k) Clearance for StronBone(TM)
2/9/2011 9:29:34 AM
More...
|
RepRegen™ Ltd. (Formerly Known as BioCeramic Therapeutics) Raises £1.03m ($1.6m) in Additional Capital from Existing Investors Imperial Innovations, Longbow Capital and Others
11/16/2010 10:52:41 AM
More...
|
RepRegen™ Ltd. (Formerly Known as BioCeramic Therapeutics)'s Chief Science Officer, Dr. Molly Stevens, is Named One of the Top-10 Scientists Under the Age of 40 in Britain
10/20/2010 10:38:16 AM
More...
|
RepRegen™ Ltd. (Formerly Known as BioCeramic Therapeutics) Discloses Six-Month in Vivo Data Confirming Bone-Regeneration Properties of Stronbone(TM) Bone Graft Substitute - the First Product from the Company's Platform to Repair and Regenerate Hard Tissue, Such as Bone
9/30/2010 9:41:48 AM
More...
|
RepRegen™ Ltd. (Formerly Known as BioCeramic Therapeutics) Is Recognized As One Of The UK's 'Top 50 University Spin-Out Companies' By Britain's Largest-Selling Daily Newspaper, The Daily Telegraph
8/5/2010 10:16:39 AM
More...
|
RepRegen™ Ltd. (Formerly Known as BioCeramic Therapeutics)(TM) Reports Data from an In Vivo Study of StronBon(TM) Bone Graft Substitute — The First Product from the Company’s Platform to Repair and Regenerate Hard Tissue, Such as Bone
6/1/2010 10:02:24 AM
More...
|
RepRegen™ Ltd. (Formerly Known as BioCeramic Therapeutics) CEO Ian Brown is Invited to Speak at the 50th Global Entrepreneurship Forum of the INSEAD Leadership Summit
5/13/2010 10:05:47 AM
More...
|
BioCeramic Therapeutics Appoints Ian Brown To CEO
1/13/2010 9:53:56 AM
More...
|
Dr Stephan Rietiker Joins BioCeramic Therapeutics' Board; Company Embarks on New Fundraising Round
1/9/2009 7:33:48 AM
More...
|
|